Acodis is a technology company.
Acodis is a technology company.
Acodis has raised $7.0M across 1 funding round.
Acodis has raised $7.0M in total across 1 funding round.
Acodis has raised $7.0M in total across 1 funding round.
Acodis's investors include Hi Inov - Dentressangle, Point Nine Capital.
Acodis is a Swiss technology company specializing in intelligent document processing (IDP) using artificial intelligence and machine learning. It builds modular AI-powered software that automatically extracts and transforms unstructured data from various document types into structured, reusable formats. Acodis primarily serves regulated industries such as pharmaceuticals, chemicals, and manufacturing, helping legal, regulatory, and operational teams automate document-heavy processes to save time, reduce errors, and improve compliance. The platform supports integration via API and can be deployed both in the cloud and on-premise, offering flexibility and scalability. Acodis has demonstrated growth momentum through multiple funding rounds, including a Series A, raising over $11 million to expand its market presence and product capabilities[1][2][3][4].
Founded in 2016 in Winterthur, Switzerland, Acodis was originally known as Turicode. The company was founded by Martin Keller, who leads as CEO. The idea emerged from the need to leverage AI to handle complex document processing challenges in highly regulated sectors, where manual review is costly and error-prone. Early traction came from successfully deploying AI solutions that could read and understand documents like humans, significantly accelerating workflows such as batch record reviews and regulatory compliance. Over time, Acodis evolved its focus to become a leader in AI-driven document automation, particularly for the pharmaceutical and healthcare industries[1][2].
Acodis rides the growing trend of AI-powered automation and intelligent document processing, which is critical as enterprises face increasing volumes of unstructured data and stringent regulatory demands. The timing is favorable due to decreasing costs of generative AI models and rising adoption of AI in compliance-heavy sectors. Market forces such as digital transformation initiatives and the need for operational excellence in pharma and manufacturing create strong demand for Acodis’ solutions. By enabling faster, more accurate document handling, Acodis influences the broader ecosystem by accelerating AI adoption in regulated industries and setting new standards for data quality and automation[1][2][3].
Looking ahead, Acodis is positioned to expand its footprint in regulated industries by enhancing its AI capabilities and broadening its product offerings, potentially integrating more advanced generative AI features for document understanding and automation. Trends such as the rise of large language models (LLMs) and regulatory digitization will shape its journey, driving demand for AI-ready, high-quality data extraction. As Acodis scales, its influence may grow beyond pharma and chemicals into other sectors requiring intelligent document processing, reinforcing its role as a key enabler of AI-driven operational transformation.
In summary, Acodis exemplifies how AI can revolutionize document-intensive workflows in regulated industries, combining advanced technology with domain expertise to deliver impactful automation solutions.
Acodis has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2023 | $7.0M Series A | Hi Inov - Dentressangle, Point Nine Capital |